Saladaga, Baby Girl Ii .

HRN: 23-53-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
AMPICILLIN 500MG (VIAL)
08/16/2023
08/22/2023
IVTT
125mg
Q12
Potentially Septic Newborn, Omphalitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: